Piper Sandler Cos. has hired David Hunker as global head of activist defense and shareholder engagement. Hunker, based in New York, will join as a managing director, according to a statement ...

Piper Sandler analyst Crispin Love maintained a Hold rating on Ready Capital (RC – Research Report) today and set a price target of ...

MINNEAPOLIS, July 23, 2024--Piper Sandler Companies to Announce Second Quarter 2024 Financial Results and Host a Conference Call on August 2, 2024 NEW YORK, June 13, 2024--Piper Sandler Companies ...

Piper Sandler analyst Michael Lavery maintained a Hold rating on Hain Celestial (HAIN – Research Report) today and set a price target of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wall Street lore presumes that September is the worst month for stocks. Piper Sandler decided to look at whether data bears that out, and if it does, whether it extends to banks, as well. The firm ...

On Tuesday, Piper Sandler maintained its Overweight rating and $30.00 price target on Central Pacific Financial (NYSE:NYSE:CPF), following a series of investor meetings last week with the company ...

Fintel reports that on August 22, 2024, Piper Sandler downgraded their outlook ... in AIZ by 8.69% over the last quarter. Bank of New York Mellon holds 2,124K shares representing 4.10% ownership ...

Piper Sandler Companies (NYSE ... Prior to that, he spent 15 years at J.P. Morgan Securities in New York and London. David founded and led their global shareholder activism defense practice ...

As you can see from the chart above the percentage of shares that are sold short for Piper Sandler has grown since its last report. This does not mean that the stock is going to fall in the near ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) turned lower on Wednesday after Piper Sandler downgraded the company, citing a more muted growth trajectory for Qelbree, its treatment for ...

9, 2024 /PRNewswire/ -- Scientia Vascular, a leader in neurovascular innovation, is pleased to announce the closing of a $14 million growth financing led by Piper Sandler Merchant Banking.